[REGN] YoY Quarter Result on 31-Dec-2016 [#Q4]

Stock
[REGN] Regeneron Pharmaceuticals, Inc.
Announcement Date
09-Feb-2017
Financial Year
2016
Quarter
31-Dec-2016 [#Q4]
Profit Trend
QoQ- -4.41%
YoY- 63.31%
Quarter Report
REGN's Result
REGN's Financial Summary
View:
Show?
Quarter Result
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
Revenue 2,169,500 1,927,800 1,582,447 1,226,827 1,098,077 802,329 610,412 23.52%
PBT 889,800 676,200 554,767 341,527 227,289 221,287 198,153 28.42%
Tax 97,800 -144,200 381,248 88,412 72,295 111,111 101,347 -0.59%
NP 792,000 820,400 173,519 253,115 154,994 110,176 96,806 41.92%
Tax Rate -10.99% 21.33% -68.72% -25.89% -31.81% -50.21% -51.15% -
Total Cost 1,377,500 1,107,400 1,408,928 973,712 943,083 692,153 513,606 17.86%
Ratio Analysis
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
NP Margin 36.51 42.56 10.97 20.63 14.12 13.73 15.86 14.90%
Per Share
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
EPS 7.25 7.58 1.62 2.41 1.49 0.89 0.98 39.56%
EPS Diluted 6.93 7.15 1.49 2.19 1.34 0.79 0.73 45.48%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.